HYPR vs ZBH · rev $7.8M vs P/E 23, rev $4.26B
Hyperfine Inc (HYPR) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Hyperfine Inc (HYPR) is a medical devices company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported HYPR revenue for 2026-06-30 was $7.8M. Net income was -$17.9M. HYPR currently screens at market cap $141.5M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
HYPR currently screens at market cap $141.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the HYPR and ZBH stock pages for the full models.
Not investment advice.